Related Experiment Video
Updated: May 1, 2026

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
Protein mislocalization: mechanisms, functions and clinical applications in cancer
1Department of Pediatrics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Abstract:
The changes from normal cells to cancer cells are primarily regulated by genome instability, which foster hallmark functions of cancer through multiple mechanisms including protein mislocalization. Mislocalization of these proteins, including oncoproteins, tumor suppressors, and other cancer-related proteins, can interfere with normal cellular function and cooperatively drive tumor development and metastasis. This review describes the cancer-related effects of protein subcellular mislocalization, the related mislocalization mechanisms, and the potential application of this knowledge to cancer diagnosis, prognosis, and therapy.
Insights
Genome instability drives cancer by altering protein location within cells. Understanding protein mislocalization offers new avenues for cancer diagnosis, prognosis, and treatment strategies.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Cancer development is intrinsically linked to genome instability.
- Protein subcellular mislocalization is a key mechanism fostering cancer hallmarks.
- Altered protein localization impacts normal cellular functions, driving tumorigenesis.
Purpose of the Study:
- To review the cancer-related effects of protein subcellular mislocalization.
- To elucidate the mechanisms underlying protein mislocalization in cancer.
- To explore the diagnostic, prognostic, and therapeutic potential of targeting protein mislocalization.
Main Methods:
- Literature review of studies on protein mislocalization in cancer.
- Analysis of mechanisms driving protein mislocalization.
- Evaluation of clinical applications of protein mislocalization knowledge.
Main Results:
- Protein mislocalization of oncoproteins, tumor suppressors, and other cancer proteins disrupts cellular homeostasis.
- Specific mechanisms contributing to mislocalization include.
- Mislocalized proteins can drive tumor initiation, progression, and metastasis.
Conclusions:
- Protein subcellular mislocalization is a critical factor in cancer progression.
- Targeting protein mislocalization presents promising opportunities for cancer therapy.
- Further research into mislocalization mechanisms can enhance cancer diagnosis and prognosis.
Related Concept Videos
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Regulated mRNA Transport
Loss of Tumor Suppressor Gene Functions
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

